Cyclerion Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cyclerion Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2023.
  • Cyclerion Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $82.4M, a 0.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $82.4M +$406K +0.5% Dec 31, 2023 10-K 2024-03-05
Q4 2022 $82M +$12.5M +18% Dec 31, 2022 10-K 2024-03-05
Q4 2021 $69.5M +$16.4M +30.9% Dec 31, 2021 10-K 2023-03-22
Q4 2020 $53.1M +$23.5M +79.2% Dec 31, 2020 10-K 2022-02-24
Q4 2019 $29.6M -$91.7M -75.6% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $121M Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.